32 results on '"Mulligan, Mark J."'
Search Results
2. Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
3. mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
4. Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
5. Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study
6. Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
7. Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
8. The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic
9. Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy
10. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
11. Metabolic Phenotypes of Response to Vaccination in Humans
12. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures
13. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study
14. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations
15. Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1
16. Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
17. High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals
18. Human Effector and Memory CD8 + T Cell Responses to Smallpox and Yellow Fever Vaccines
19. 90 - Vacunas
20. 90 - Vaccines
21. A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
22. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
23. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
24. Colaboradores
25. List of Contributors
26. Editorial overview: Preventive and therapeutic vaccines
27. Era of global Ebola: risk of exposure in health-care workers
28. Bacteriostatic Versus Bactericidal Activity
29. Cell Fusion Activity of the Simian Immunodeficiency Virus Envelope Protein Is Modulated by the Intracytoplasmic Domain
30. The Matrix Protein of HIV-1 Is Not Sufficient for Assembly and Release of Virus-like Particles
31. HIV Vaccine Acceptance Among HeterosexualClients of a Sexually Transmitted Diseases Clinic
32. Case Report: Neoplastic Meningitis with Eosinophilic Pleocytosis in Hodgkin’s Disease: A Case with Cerebellar Dysfunction and a Review of the Literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.